Observed Signal · Jul 12, 2026 · Market Signal · Source: MarketsandMarkets · Impact: 4/5
Food as Medicine Market worth $400.81 billion by 2031
The report "Food as Medicine Market" by Product Type (Functional Foods, Medical Foods, Nutraceuticals, Personalized Nutrition Products, Therapeutic Food Products), Function (Metabolic Health, Diabetes Management, Cardiovascular Health, Gastrointestinal Health, Immune Health, Other Functions), Ingredient Type, Source, Form, Distribution Channel, Prescription Type (Qualitative), and Region – Global Forecast to 2031. The food as medicine market is estimated at USD 254.15 billion in 2026 and is projected to reach USD 400.81 billion by 2031, at a CAGR of 9.5% from 2026 to 2031.
Track MarketsandMarkets Signals & Market Shifts in Real-Time
Polaris7 autonomous intelligence agents track regulatory filings, primary sources, executive changes, and deal flow 24/7. Create your free Explorer workspace to monitor these entities.
Connected Companies & Entities
1 Entity mappedRelated Market Signals & Shifts
Recent verified developments and strategic activity across this market segment.
Identity Verification Market to Reach $33.36B by 2031
MarketsandMarkets projects the global identity verification market to grow from $16.48 billion in 2026 to $33.36 billion by 2031, at a CAGR of 15.1%. The report highlights key drivers such as digital onboarding, remote transactions, and increasing regulatory requirements. The solutions segment is expected to dominate, with the on-premises deployment leading. Asia Pacific is projected to register the highest CAGR. The market is seeing significant M&A activity, including acquisitions by Socure, Signicat, and LexisNexis Risk Solutions. Notable investments include Persona's $200M Series D and Socure's recent growth funding. The report also lists major players and emphasizes a shift toward unified platforms integrating verification, fraud prevention, and risk assessment.
Cold Chain Monitoring Market to Reach $19.54B by 2032
MarketsandMarkets projects the global cold chain monitoring market to grow from USD 9.50 billion in 2026 to USD 19.54 billion by 2032, at a CAGR of 12.8%. The growth is driven by increasing demand for real-time temperature monitoring, shipment visibility, automated alerts, and regulatory compliance across pharmaceuticals, food & beverage, healthcare, logistics, and retail. Key segments include the chilled temperature type, software offerings, and the transportation logistics segment. North America is expected to dominate in 2025, while Asia Pacific leads by 2032. Major players include Carrier, ORBCOMM, Controlant, Cryoport, and Testo.
Clinical Trial Supplies Market to Reach $8.95B by 2031
MarketsandMarkets forecasts the clinical trial supplies market to grow from USD 5.60 billion in 2026 to USD 8.95 billion by 2031, at a CAGR of 8.9%. The report highlights logistics and distribution as the largest service segment, small molecules as the dominant molecule type, and oncology as the leading therapeutic area. North America accounts for over 41.4% of global revenue. Key drivers include rising clinical trial numbers, increased R&D spending, and decentralized trial adoption. The report also details major M&A activity, including DHL's acquisition of CRYOPDP and UPS's acquisition of Andlauer Healthcare Group, reflecting consolidation in cold-chain logistics.
Track Real-Time Market Signals & Shifts
Set up custom watchlists to receive automated, evidence-grounded executive digests whenever material signals or shifts occur across your tracked landscape.